IndraLab
Statements
reach
"Based on the in vitro assessments, this miRNA directly targets cylindromatosis (CYLD) (a negative regulator of antiviral responses through removing lysine (K)-63-linked polyubiquitin of RIG-I), increases RIG-I ubiquitination and thereupon production of IFNs-I [109].7
hsa-miRNAs and SARS-CoV-2-induced interfering factors."
| PMC